Calcium channel antagonists prevent cardiovascular events in Japanese patients with myocardial infarction even in the absence of coronary artery spasm

Circulation Journal

Volumn 75, Issue 7, 2011, Pages 1577-1578

  Sakamoto, Tomohiro ^a   Nakao, Koichi ^a   Ogawa, Hisao ^b  

^a SAISEIKAI KUMAMOTO HOSPITAL   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ATENOLOL; BENIDIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT;

ACUTE HEART INFARCTION; CARDIOVASCULAR DISEASE; CORONARY ARTERY SPASM; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; EDITORIAL; ETHNIC DIFFERENCE; HEART FAILURE; HEART PROTECTION; HUMAN; JAPANESE; PROGNOSIS; SECONDARY PREVENTION; UNSTABLE ANGINA PECTORIS; VASOCONSTRICTION;

ADRENERGIC BETA-ANTAGONISTS; CALCIUM CHANNEL BLOCKERS; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; SECONDARY PREVENTION;

EID: 79959734807     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-0471     Document Type: Editorial

References (12)

1. Maseri A, Kaski JC. Pathogenetic mechanisms of coronary artery spasm. J Am Coll Cardiol 1989; 14: 610-612.
2. Yasue H, Horio Y, Nakamura N, Fujii H, Imoto N, Sonoda R, et al. Induction of coronary artery spasm by acetylcholine in patients with variant angina: Possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. Circulation 1986; 74: 955-963.
3. Pristipino C, Beltrame JF, Finocchiaro ML, Hattori R, Fujita M, Mongiardo R, et al. Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction. Circulation 2000; 101: 1102-1108.
4. Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Kugiyama K, Ogawa H, et al. T-786→C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronaryspasm. Circulation 1999; 99: 2864-2870.
5. Yasue H, Takizawa A, Nagao M, Nishida S, Horie M, Kubota J, et al. Long-term prognosis for patients with variant angina and influential factors. Circulation 1988; 78: 1-9.
6. Fukumoto Y, Yasuda S, Ito A, Shimokawa H. Prognostic effects of benidipine in patients with vasospastic angina: Comparison with diltiazem and amlodipine. J Cardiovasc Pharmacol 2008; 51: 253-257.
7. Yasue H, Omote S, Takizawa A, Nagao M. Coronary arterial spasm in ischemic heart disease and its pathogenesis: A review. Circ Res 1983; 52(Suppl 1): 147-152.
8. JCS joint working group. Guidelines for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina) (JCS 2008): Digest version. Circ J 2010; 74: 1745-1762.
9. Lange RA, Cigarroa RG, Flores ED, McBride W, Kim AS, Wells PJ, et al. Potentiation of cocaine-induced coronary vasoconstriction by beta-adrenergic blockade Ann Intern Med 1990; 112: 897-903.
10. Kohro T, Hayashi D, Yamazaki T, Nagai R; JCAD Investigators. Beta-blocker prescription among Japanese cardiologists and its effect on various outcomes. Circ J 2010; 74: 962-969.
11. Japanese beta-Blockers and Calcium Antagonists Myocardial Infarction (JBCMI) Investigators. Comparison of the effects of beta blockers and calcium antagonists on cardiovascular events after acute myocardial infarction in Japanese subjects. Am J Cardiol 2004; 93: 969-973.
12. Nakagomi A, Kodani E, Takano H, Uchida T, Sato N, Ibuki C, et al. Secondary preventive effects of a calcium antagonist for ischemic heart attack: Randomized parallel comparison with β-blockers. Circ J 2011; 75: 1696-1705.